Developing Therapy for Every Kid With Cancer – Summary of a Scientific Session at the 2023 <scp>ASCPT</scp> Meeting-Reference-Cited by-同舟云学术

Developing Therapy for Every Kid With Cancer – Summary of a Scientific Session at the 2023 ASCPT Meeting

Published:2023-11-24 Issue:2 Volume:115 Page:185-187
ISSN:0009-9236
Container-title:Clinical Pharmacology & Therapeutics
language:en
Short-container-title:Clin Pharma and Therapeutics

Author:

Moore Jason N.¹,Campagne Olivia²,Bhojwani Deepa³,Crowe Dean⁴,Stewart Clinton F.⁵^ORCID

Affiliation:

1. Office of Clinical Pharmacology, Center for Drug Evaluation and Research US Food and Drug Administration Silver Spring Maryland USA

2. Quantitative Clinical Pharmacology Takeda Development Center Americas, Inc. Cambridge Massachusetts USA

3. Division of Pediatric Hematology Oncology, Children's Hospital Los Angeles, Norris Comprehensive Cancer Center and Keck School of Medicine University of Southern California Los Angeles California USA

4. Rally Foundation for Childhood Cancer Research Atlanta Georgia USA

5. Department of Pharmacy and Pharmaceutical Sciences St. Jude Children's Research Hospital Memphis Tennessee USA

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://ascpt.onlinelibrary.wiley.com/doi/pdf/10.1002/cpt.3101

Reference10 articles.

1. Clinical pharmacology of cytotoxic drugs in neonates and infants: Providing evidence-based dosing guidance

2. Methods used for pediatric dose selection in drug development programs submitted to the US FDA 2012‐2020;Green F.G.;J. Clin. Pharmacol.,2021

3. Exposure–Toxicity Association of Cyclophosphamide and Its Metabolites in Infants and Young Children with Primary Brain Tumors: Implications for Dosing

4. Bureau U.S.C.2022 Census Illuminates Racial and Ethnic Composition of the Country(2021).

5. Does socioeconomic status account for racial and ethnic disparities in childhood cancer survival?